Pharma Mar, S.A.
PHMMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,373 | $749 | $1,170 | $993 |
| - Cash | $63 | $60 | $150 | $113 |
| + Debt | $51 | $44 | $43 | $49 |
| Enterprise Value | $1,361 | $733 | $1,063 | $929 |
| Revenue | $175 | $158 | $196 | $230 |
| % Growth | 10.6% | -19.5% | -14.6% | – |
| Gross Profit | $167 | $149 | $183 | $213 |
| % Margin | 95.3% | 93.9% | 93.1% | 92.8% |
| EBITDA | $21 | $5 | $52 | $104 |
| % Margin | 12.1% | 2.9% | 26.5% | 45.3% |
| Net Income | $26 | $1 | $49 | $93 |
| % Margin | 14.9% | 0.7% | 25.1% | 40.4% |
| EPS Diluted | 1.49 | 0.064 | 2.73 | 5.13 |
| % Growth | 2,246.5% | -97.7% | -46.8% | – |
| Operating Cash Flow | $6 | -$13 | $38 | $26 |
| Capital Expenditures | -$16 | -$16 | -$9 | -$8 |
| Free Cash Flow | -$9 | -$29 | $29 | $18 |